Effect of blocking the transforming growth factor-beta signaling pathway on tumor-specific cytotoxic T lym-phocytes

Feng TIAN,Kai ZHOU,Xiao-ling CHE,Dian FU,Wen CHENG,Wen-quan ZHOU,Zheng-yu ZHANG,Wei-jun QIN,Long-xin WANG

DOI: https://doi.org/10.3969/j.issn.1008-8199.2015.03.004

2015-01-01

Abstract:Objective Cytotoxic T lymphocytes ( CTLs) are final effect tumor-killer cells in the body and their immune func-tion can be suppressed by the transforming growth factor-beta ( TGF-β) secreted from the tumor .We observed the effect of blocking the TGF-βsignaling pathway on tumor-specific CTLs. Methods Tumor lysate-pulsed CTLs (TP-CTLs) were activated to be sensitive to mouse renal cancer cells with dendritic cells and transfected with a retrovirus containing dominant -negative TGF-βtype Ⅱ receptor ( TβRⅡDN) for isolation of TGF-β-insensitive tumor-specific TβRⅡDN-CTLs.Western blot was used to measure the level of phos-phorylated Smad-2 and evaluate the inhibitory effect of TGF-βon the proliferation of CTLs .The cytotoxic effect of TGF-βwas detected by 51 Cr releasing test , and the levels of serum IL-2 and INF-γin the mouse model determined by ELISA . Results TGF-βshowed a significantly lower rate of inhibition on the proliferation of the TβRⅡDN-CTLs than on that of the TP-CTLs (2.08%vs 65.96%, P<0.01).In the effect-target ratio of 100∶1, the cytotoxic effect of TGF-βon the TβRⅡDN-CTLs was markedly higher than that on the TP-CTLs ([50.4 ±4.48]%vs [17.7 ±1.42]%, P<0.01), and so were the levels of serum IL-2 ([1541.05 ±36.75] pg/mL vs <br> [850.34 ±27.22]pg/mL, P<0.01) and INF-γ([285.42 ±17.61] pg/mL vs [163.25 ±6.35] pg/mL, P <0.01). Conclusion <br> Blocking the TGF-βsignaling pathway of tumor-specific CTLs can overcome the immunosuppressive effect of tumor cells and improve the cytotoxic efficiency of CTLs .